News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,785 Results
Type
Article (61290)
Company Profile (71)
Press Release (584424)
Multimedia
Podcasts (61)
Webinars (13)
Section
Business (173712)
Career Advice (2730)
Deals (32419)
Drug Delivery (97)
Drug Development (76870)
Employer Resources (150)
FDA (14937)
Job Trends (13885)
News (304918)
Policy (28964)
Tag
Academia (2894)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (90)
Alliances (43175)
ALS (92)
Alzheimer's disease (1324)
Antibody-drug conjugate (ADC) (116)
Approvals (14946)
Artificial intelligence (272)
Autoimmune disease (24)
Automation (15)
Bankruptcy (290)
Best Places to Work (10853)
BIOSECURE Act (16)
Biosimilars (102)
Biotechnology (53)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (285)
Cancer (2230)
Cardiovascular disease (169)
Career advice (2313)
Career pathing (33)
CAR-T (157)
Cell therapy (439)
Cervical cancer (21)
Clinical research (62584)
Collaboration (807)
Company closure (2)
Compensation (342)
Complete response letters (20)
COVID-19 (2572)
CRISPR (45)
C-suite (270)
Cystic fibrosis (102)
Data (2244)
Decentralized trials (2)
Denatured (26)
Depression (44)
Diabetes (257)
Diagnostics (6161)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (114)
Drug pricing (100)
Drug shortages (23)
Duchenne muscular dystrophy (89)
Earnings (60420)
Editorial (41)
Employer branding (18)
Employer resources (132)
Events (94584)
Executive appointments (774)
FDA (16290)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (764)
Gene editing (114)
Generative AI (20)
Gene therapy (307)
GLP-1 (671)
Government (4480)
Grass and pollen (6)
Guidances (146)
Healthcare (18209)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (112)
Indications (28)
Infectious disease (2708)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (97)
Interviews (527)
IPO (14803)
IRA (38)
Job creations (3414)
Job search strategy (1941)
Kidney cancer (10)
Labor market (34)
Layoffs (512)
Leadership (22)
Legal (6438)
Liver cancer (70)
Lung cancer (308)
Lymphoma (147)
Machine learning (9)
Management (53)
Manufacturing (292)
MASH (69)
Medical device (12659)
Medtech (12664)
Mergers & acquisitions (18217)
Metabolic disorders (648)
Multiple sclerosis (79)
NASH (13)
Neurodegenerative disease (85)
Neuropsychiatric disorders (26)
Neuroscience (1851)
NextGen: Class of 2025 (6374)
Non-profit (4316)
Now hiring (13)
Obesity (326)
Opinion (232)
Ovarian cancer (76)
Pain (96)
Pancreatic cancer (84)
Parkinson's disease (143)
Partnered (21)
Patents (242)
Patient recruitment (115)
Peanut (50)
People (59603)
Pharmaceutical (20)
Pharmacy benefit managers (16)
Phase I (19701)
Phase II (27621)
Phase III (20156)
Pipeline (1280)
Policy (133)
Postmarket research (2470)
Preclinical (8417)
Press Release (67)
Prostate cancer (108)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (367)
Real estate (5992)
Recruiting (61)
Regulatory (20147)
Reports (34)
Research institute (2403)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (69)
Series A (132)
Series B (89)
Service/supplier (9)
Sickle cell disease (52)
Special edition (12)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3344)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (31)
The Weekly (33)
Vaccines (671)
Venture capitalists (35)
Weight loss (202)
Women's health (31)
Worklife (19)
Date
Today (27)
Last 7 days (887)
Last 30 days (2801)
Last 365 days (30197)
2025 (11046)
2024 (32277)
2023 (36343)
2022 (46622)
2021 (51588)
2020 (50744)
2019 (44793)
2018 (34075)
2017 (30710)
2016 (30055)
2015 (35443)
2014 (28380)
2013 (24948)
2012 (26218)
2011 (26457)
2010 (24937)
Location
Africa (871)
Alabama (55)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38080)
Australia (6850)
California (5776)
Canada (1903)
China (496)
Colorado (253)
Connecticut (263)
Delaware (148)
Europe (88660)
Florida (879)
Georgia (205)
Idaho (56)
Illinois (558)
India (25)
Indiana (285)
Iowa (10)
Japan (162)
Kansas (97)
Kentucky (24)
Louisiana (11)
Maine (61)
Maryland (851)
Massachusetts (4163)
Michigan (226)
Minnesota (348)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (61)
New Hampshire (61)
New Jersey (1693)
New Mexico (29)
New York (1679)
North Carolina (975)
North Dakota (9)
Northern California (2523)
Ohio (198)
Oklahoma (15)
Oregon (36)
Pennsylvania (1274)
Puerto Rico (13)
Rhode Island (31)
South America (1177)
South Carolina (19)
South Dakota (1)
Southern California (2210)
Tennessee (99)
Texas (881)
United States (21929)
Utah (180)
Virginia (147)
Washington D.C. (52)
Washington State (521)
West Virginia (3)
Wisconsin (62)
645,785 Results for "university of alberta".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PlasCred Circular Innovations Inc. Announces Alberta Innovates Funding Grant
April 8, 2025
·
6 min read
Business
Nanostics Receives Funding from the University of Alberta Innovation Fund to Propel Adoption of the ClarityDX Prostate Test
University of Alberta Innovation Fund invests in Nanostics to support adoption of its ClarityDX Prostate test.
April 23, 2024
·
3 min read
Press Releases
Alberta sets a new standard for advanced prostate cancer treatment with public reimbursement of Pluvicto™
March 10, 2025
·
4 min read
Press Releases
Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics
March 12, 2025
·
6 min read
The Alberta Cancer Foundation, Alberta Health Services and the University of Calgary announce largest donation in Alberta Health Service’s history to the new Calgary Cancer Centre
The Alberta Cancer Foundation, Alberta Health Services and the University of Calgary are thrilled to announce a historic and transformational $50 million donation to the Calgary Cancer Centre from the Arthur J.E. Child Foundation.
June 28, 2023
·
7 min read
Press Releases
Abbott’s FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta
December 18, 2024
·
3 min read
Press Releases
Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta
September 9, 2024
·
14 min read
Business
Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes
Adhera Therapeutics, Inc. (OTCQB: ATRX) (“Adhera” or the “Company”), a clinical stage biopharmaceutical company, is pleased to announce that the Company is to commence a dose finding study of MLR-1023 (tolimidone) in Type 1 Diabetes in collaboration with the Alberta Diabetes Institute (“ADI”) at the University of Alberta (“U of A”), located in Edmonton, Alberta, Canada.
January 25, 2023
·
6 min read
Alberta Cancer Foundation announces initial investment of its novel philanthropic Breakthrough Fund to support early-stage cancer research
The Alberta Cancer Foundation is thrilled to announce that Entos Pharmaceuticals and 48Hour Discovery are the first recipients of its new Breakthrough Fund, an innovative, philanthropic vehicle that will support important research opportunities with the potential to accelerate cancer care and treatment through to commercialization.
January 23, 2024
·
5 min read
Nanostics Launches ClarityDX Prostate Test in Alberta to Significantly Improve Prostate Cancer Screening
Nanostics is thrilled to announce the availability of the ClarityDX Prostate test at its newly accredited clinical lab in Edmonton, Alberta.
September 28, 2023
·
3 min read
1 of 64,579
Next
